APO Research
Talk to an analyst

APO RESEARCH · REPORT

Amiodarone

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Amiodarone Industry Growth and Trends Forecast to 2032

20 December 2025100 pages

Choose your research edition.

Industry ResearchAmiodarone Industry Research Report 2026127 pages · $2,950 USDIndustry Growth & TrendsGlobal Amiodarone Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Amiodarone Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Amiodarone Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Amiodarone Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Amiodarone market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Amiodarone is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Amiodarone is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Amiodarone is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Amiodarone include Shanghai Pharmaceuticals, Sanofi, Mylan Pharmaceuticals, North China Pharmaceutical Company, Harbin Pharmaceutical Group, Wyeth Pharmaceuticals (Pfizer), Sawai Pharmaceutical, Roemmers and Cipla Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Amiodarone market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Amiodarone market size, estimates, and forecasts are presented in terms of sales volume (m units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Amiodarone market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Amiodarone.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Amiodarone market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Amiodarone Market by Company

Shanghai Pharmaceuticals

Sanofi

Mylan Pharmaceuticals

North China Pharmaceutical Company

Harbin Pharmaceutical Group

Wyeth Pharmaceuticals (Pfizer)

Sawai Pharmaceutical

Roemmers

Cipla Pharmaceutical

Arrow Pharma Pty Ltd

Amiodarone Segment by Type

Injection Amiodarone

Tablet Amiodarone

Capsule Amiodarone

Amiodarone Segment by Application

Ventricular Tachycardia

Atrial Fibrillation

Cardiac Arrest

Others

Amiodarone Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Amiodarone market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Amiodarone and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Amiodarone.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Amiodarone manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Amiodarone in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Injection Amiodarone Table 2. Major Company of Tablet Amiodarone Table 3. Major Company of Capsule Amiodarone Table 4. Global Amiodarone Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Amiodarone Sales by Type (2021-2026) & (m units) Table 6. Global Amiodarone Sales Market Share in Volume by Type (2021-2026) Table 7. Global Amiodarone Sales by Type (2021-2026) & (US$ Million) Table 8. Global Amiodarone Sales Market Share in Value by Type (2021-2026) Table 9. Global Amiodarone Price by Type (2021-2026) & (US$/k unit) Table 10. Global Amiodarone Sales by Type (2027-2032) & (m units) Table 11. Global Amiodarone Sales Market Share in Volume by Type (2027-2032) Table 12. Global Amiodarone Sales by Type (2027-2032) & (US$ Million) Table 13. Global Amiodarone Sales Market Share in Value by Type (2027-2032) Table 14. Global Amiodarone Price by Type (2027-2032) & (US$/k unit) Table 15. North America Amiodarone Sales by Type (2021-2026) & (m units) Table 16. North America Amiodarone Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Amiodarone Sales by Type (2021-2026) & (m units) Table 18. Europe Amiodarone Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Amiodarone Sales by Type (2021-2026) & (m units) Table 20. Asia-Pacific Amiodarone Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Amiodarone Sales by Type (2021-2026) & (m units) Table 22. Latin America Amiodarone Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Amiodarone Sales by Type (2021-2026) & (m units) Table 24. Middle East and Africa Amiodarone Sales by Type (2021-2026) & (US$ Million) Table 25. Amiodarone Industry Trends Table 26. Amiodarone Industry Drivers Table 27. Amiodarone Industry Opportunities and Challenges Table 28. Amiodarone Industry Restraints Table 29. Global Amiodarone Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Amiodarone Revenue Market Share by Company (2021-2026) Table 31. Global Amiodarone Sales by Company (2021-2026) & (m units) Table 32. Global Amiodarone Sales Share by Company (2021-2026) Table 33. Global Amiodarone Market Price by Company (2021-2026) & (US$/k unit) Table 34. Global Amiodarone Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Amiodarone Major Company Production Sites and Headquarters Table 36. Global Amiodarone Company, Product Type & Application Table 37. Global Amiodarone Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Amiodarone by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Amiodarone Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Amiodarone Sales by Region (2021-2026) & (m units) Table 42. Global Amiodarone Sales Market Share in Volume by Region (2021-2026) Table 43. Global Amiodarone Sales by Region (2021-2026) & (US$ Million) Table 44. Global Amiodarone Sales Market Share in Value by Region (2021-2026) Table 45. Global Amiodarone Sales (m units), Value (US$ Million), Price (US$/k unit) and Gross Margin (2021-2026) Table 46. Global Amiodarone Sales by Region (2027-2032) & (m units) Table 47. Global Amiodarone Sales Market Share in Volume by Region (2027-2032) Table 48. Global Amiodarone Sales by Region (2027-2032) & (US$ Million) Table 49. Global Amiodarone Sales Market Share in Value by Region (2027-2032) Table 50. Global Amiodarone Sales (m units), Value (US$ Million), Price (US$/k unit) and Gross Margin (2027-2032) Table 51. Global Amiodarone Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Amiodarone Sales by Application (2021-2026) & (m units) Table 53. Global Amiodarone Sales Market Share in Volume by Application (2021-2026) Table 54. Global Amiodarone Sales by Application (2021-2026) & (US$ Million) Table 55. Global Amiodarone Sales Market Share in Value by Application (2021-2026) Table 56. Global Amiodarone Price by Application (2021-2026) & (US$/k unit) Table 57. Global Amiodarone Sales by Application (2027-2032) & (m units) Table 58. Global Amiodarone Sales Market Share in Volume by Application (2027-2032) Table 59. Global Amiodarone Sales by Application (2027-2032) & (US$ Million) Table 60. Global Amiodarone Sales Market Share in Value by Application (2027-2032) Table 61. Global Amiodarone Price by Application (2027-2032) & (US$/k unit) Table 62. North America Amiodarone Sales by Application (2021-2026) & (m units) Table 63. North America Amiodarone Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Amiodarone Sales by Application (2021-2026) & (m units) Table 65. Europe Amiodarone Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Amiodarone Sales by Application (2021-2026) & (m units) Table 67. Asia-Pacific Amiodarone Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Amiodarone Sales by Application (2021-2026) & (m units) Table 69. Latin America Amiodarone Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Amiodarone Sales by Application (2021-2026) & (m units) Table 71. Middle East and Africa Amiodarone Sales by Application (2021-2026) & (US$ Million) Table 72. Shanghai Pharmaceuticals Company Information Table 73. Shanghai Pharmaceuticals Business Overview Table 74. Shanghai Pharmaceuticals Amiodarone Sales (m units), Revenue (US$ Million), Price (US$/k unit) and Gross Margin (2021-2026) Table 75. Shanghai Pharmaceuticals Amiodarone Product Portfolio Table 76. Shanghai Pharmaceuticals Recent Development Table 77. Sanofi Company Information Table 78. Sanofi Business Overview Table 79. Sanofi Amiodarone Sales (m units), Revenue (US$ Million), Price (US$/k unit) and Gross Margin (2021-2026) Table 80. Sanofi Amiodarone Product Portfolio Table 81. Sanofi Recent Development Table 82. Mylan Pharmaceuticals Company Information Table 83. Mylan Pharmaceuticals Business Overview Table 84. Mylan Pharmaceuticals Amiodarone Sales (m units), Revenue (US$ Million), Price (US$/k unit) and Gross Margin (2021-2026) Table 85. Mylan Pharmaceuticals Amiodarone Product Portfolio Table 86. Mylan Pharmaceuticals Recent Development Table 87. North China Pharmaceutical Company Company Information Table 88. North China Pharmaceutical Company Business Overview Table 89. North China Pharmaceutical Company Amiodarone Sales (m units), Revenue (US$ Million), Price (US$/k unit) and Gross Margin (2021-2026) Table 90. North China Pharmaceutical Company Amiodarone Product Portfolio Table 91. North China Pharmaceutical Company Recent Development Table 92. Harbin Pharmaceutical Group Company Information Table 93. Harbin Pharmaceutical Group Business Overview Table 94. Harbin Pharmaceutical Group Amiodarone Sales (m units), Revenue (US$ Million), Price (US$/k unit) and Gross Margin (2021-2026) Table 95. Harbin Pharmaceutical Group Amiodarone Product Portfolio Table 96. Harbin Pharmaceutical Group Recent Development Table 97. Wyeth Pharmaceuticals (Pfizer) Company Information Table 98. Wyeth Pharmaceuticals (Pfizer) Business Overview Table 99. Wyeth Pharmaceuticals (Pfizer) Amiodarone Sales (m units), Revenue (US$ Million), Price (US$/k unit) and Gross Margin (2021-2026) Table 100. Wyeth Pharmaceuticals (Pfizer) Amiodarone Product Portfolio Table 101. Wyeth Pharmaceuticals (Pfizer) Recent Development Table 102. Sawai Pharmaceutical Company Information Table 103. Sawai Pharmaceutical Business Overview Table 104. Sawai Pharmaceutical Amiodarone Sales (m units), Revenue (US$ Million), Price (US$/k unit) and Gross Margin (2021-2026) Table 105. Sawai Pharmaceutical Amiodarone Product Portfolio Table 106. Sawai Pharmaceutical Recent Development Table 107. Roemmers Company Information Table 108. Roemmers Business Overview Table 109. Roemmers Amiodarone Sales (m units), Revenue (US$ Million), Price (US$/k unit) and Gross Margin (2021-2026) Table 110. Roemmers Amiodarone Product Portfolio Table 111. Roemmers Recent Development Table 112. Cipla Pharmaceutical Company Information Table 113. Cipla Pharmaceutical Business Overview Table 114. Cipla Pharmaceutical Amiodarone Sales (m units), Revenue (US$ Million), Price (US$/k unit) and Gross Margin (2021-2026) Table 115. Cipla Pharmaceutical Amiodarone Product Portfolio Table 116. Cipla Pharmaceutical Recent Development Table 117. Arrow Pharma Pty Ltd Company Information Table 118. Arrow Pharma Pty Ltd Business Overview Table 119. Arrow Pharma Pty Ltd Amiodarone Sales (m units), Revenue (US$ Million), Price (US$/k unit) and Gross Margin (2021-2026) Table 120. Arrow Pharma Pty Ltd Amiodarone Product Portfolio Table 121. Arrow Pharma Pty Ltd Recent Development Table 122. North America Amiodarone Market Size Growth Rate (CAGR) by Country (m units): 2021 VS 2025 VS 2032 Table 123. North America Amiodarone Sales by Country (2021-2026) & (m units) Table 124. North America Amiodarone Sales Market Share by Country (2021-2026) Table 125. North America Amiodarone Sales Forecast by Country (2027-2032) & (m units) Table 126. North America Amiodarone Sales Market Share Forecast by Country (2027-2032) Table 127. North America Amiodarone Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 128. North America Amiodarone Market Size by Country (2021-2026) & (US$ Million) Table 129. North America Amiodarone Market Share by Country (2021-2026) Table 130. North America Amiodarone Market Size Forecast by Country (2027-2032) & (US$ Million) Table 131. North America Amiodarone Market Share Forecast by Country (2027-2032) Table 132. Europe Amiodarone Market Size Growth Rate (CAGR) by Country (m units): 2021 VS 2025 VS 2032 Table 133. Europe Amiodarone Sales by Country (2021-2026) & (m units) Table 134. Europe Amiodarone Sales Market Share by Country (2021-2026) Table 135. Europe Amiodarone Sales Forecast by Country (2027-2032) & (m units) Table 136. Europe Amiodarone Sales Market Share Forecast by Country (2027-2032) Table 137. Europe Amiodarone Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 138. Europe Amiodarone Market Size by Country (2021-2026) & (US$ Million) Table 139. Europe Amiodarone Market Share by Country (2021-2026) Table 140. Europe Amiodarone Market Size Forecast by Country (2027-2032) & (US$ Million) Table 141. Europe Amiodarone Market Share Forecast by Country (2027-2032) Table 142. Asia-Pacific Amiodarone Market Size Growth Rate (CAGR) by Country (m units): 2021 VS 2025 VS 2032 Table 143. Asia-Pacific Amiodarone Sales by Country (2021-2026) & (m units) Table 144. Asia-Pacific Amiodarone Sales Market Share by Country (2021-2026) Table 145. Asia-Pacific Amiodarone Sales Forecast by Country (2027-2032) & (m units) Table 146. Asia-Pacific Amiodarone Sales Market Share Forecast by Country (2027-2032) Table 147. Asia-Pacific Amiodarone Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 148. Asia-Pacific Amiodarone Market Size by Country (2021-2026) & (US$ Million) Table 149. Asia-Pacific Amiodarone Market Share by Country (2021-2026) Table 150. Asia-Pacific Amiodarone Market Size Forecast by Country (2027-2032) & (US$ Million) Table 151. Asia-Pacific Amiodarone Market Share Forecast by Country (2027-2032) Table 152. Latin America Amiodarone Market Size Growth Rate (CAGR) by Country (m units): 2021 VS 2025 VS 2032 Table 153. Latin America Amiodarone Sales by Country (2021-2026) & (m units) Table 154. Latin America Amiodarone Sales Market Share by Country (2021-2026) Table 155. Latin America Amiodarone Sales Forecast by Country (2027-2032) & (m units) Table 156. Latin America Amiodarone Sales Market Share Forecast by Country (2027-2032) Table 157. Latin America Amiodarone Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 158. Latin America Amiodarone Market Size by Country (2021-2026) & (US$ Million) Table 159. Latin America Amiodarone Market Share by Country (2021-2026) Table 160. Latin America Amiodarone Market Size Forecast by Country (2027-2032) & (US$ Million) Table 161. Latin America Amiodarone Market Share Forecast by Country (2027-2032) Table 162. Middle East and Africa Amiodarone Market Size Growth Rate (CAGR) by Country (m units): 2021 VS 2025 VS 2032 Table 163. Middle East and Africa Amiodarone Sales by Country (2021-2026) & (m units) Table 164. Middle East and Africa Amiodarone Sales Market Share by Country (2021-2026) Table 165. Middle East and Africa Amiodarone Sales Forecast by Country (2027-2032) & (m units) Table 166. Middle East and Africa Amiodarone Sales Market Share Forecast by Country (2027-2032) Table 167. Middle East and Africa Amiodarone Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 168. Middle East and Africa Amiodarone Market Size by Country (2021-2026) & (US$ Million) Table 169. Middle East and Africa Amiodarone Market Share by Country (2021-2026) Table 170. Middle East and Africa Amiodarone Market Size Forecast by Country (2027-2032) & (US$ Million) Table 171. Middle East and Africa Amiodarone Market Share Forecast by Country (2027-2032) Table 172. Key Raw Materials Table 173. Raw Materials Key Suppliers Table 174. Amiodarone Distributors List Table 175. Amiodarone Customers List Table 176. Research Programs/Design for This Report Table 177. Authors List of This Report Table 178. Secondary Sources Table 179. Primary Sources List of Figures Figure 1. Amiodarone Image Figure 2. Global Amiodarone Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Amiodarone Market Size (2021-2032) & (US$ Million) Figure 4. Global Amiodarone Sales (2021-2032) & (m units) Figure 5. Injection Amiodarone Image Figure 6. Global Injection Amiodarone Sales YoY Growth (2021-2032) & (m units) Figure 7. Tablet Amiodarone Image Figure 8. Global Tablet Amiodarone Sales YoY Growth (2021-2032) & (m units) Figure 9. Capsule Amiodarone Image Figure 10. Global Capsule Amiodarone Sales YoY Growth (2021-2032) & (m units) Figure 11. Global Amiodarone Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Amiodarone Market Share by Type 2025 VS 2032 Figure 13. North America Amiodarone Sales Market Share in Volume by Type in 2025 Figure 14. North America Amiodarone Sales Market Share in Value by Type in 2025 Figure 15. Europe Amiodarone Sales Market Share in Volume by Type in 2025 Figure 16. Europe Amiodarone Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Amiodarone Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Amiodarone Sales Market Share in Value by Type in 2025 Figure 19. Latin America Amiodarone Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Amiodarone Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Amiodarone Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Amiodarone Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Amiodarone Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Ventricular Tachycardia Image Figure 26. Global Ventricular Tachycardia Sales YoY Growth (2021-2032) & (m units) Figure 27. Atrial Fibrillation Image Figure 28. Global Atrial Fibrillation Sales YoY Growth (2021-2032) & (m units) Figure 29. Cardiac Arrest Image Figure 30. Global Cardiac Arrest Sales YoY Growth (2021-2032) & (m units) Figure 31. Others Image Figure 32. Global Others Sales YoY Growth (2021-2032) & (m units) Figure 33. Global Amiodarone Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Amiodarone Market Share by Application 2025 VS 2032 Figure 35. North America Amiodarone Sales Market Share in Volume by Application in 2025 Figure 36. North America Amiodarone Sales Market Share in Value by Application in 2025 Figure 37. Europe Amiodarone Sales Market Share in Volume by Application in 2025 Figure 38. Europe Amiodarone Sales Market Share in Value by Application in 2025 Figure 39. Asia-Pacific Amiodarone Sales Market Share in Volume by Application in 2025 Figure 40. Asia-Pacific Amiodarone Sales Market Share in Value by Application in 2025 Figure 41. Latin America Amiodarone Sales Market Share in Volume by Application in 2025 Figure 42. Latin America Amiodarone Sales Market Share in Value by Application in 2025 Figure 43. Middle East and Africa Amiodarone Sales Market Share in Volume by Application in 2025 Figure 44. Middle East and Africa Amiodarone Sales Market Share in Value by Application in 2025 Figure 45. North America Amiodarone Sales by Country: 2021 VS 2025 VS 2032 (m units) Figure 46. North America Amiodarone Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. North America Amiodarone Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. North America Amiodarone Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Amiodarone Sales by Country: 2021 VS 2025 VS 2032 (m units) Figure 50. Europe Amiodarone Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Amiodarone Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Europe Amiodarone Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Amiodarone Sales by Country: 2021 VS 2025 VS 2032 (m units) Figure 54. Asia-Pacific Amiodarone Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Amiodarone Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Asia-Pacific Amiodarone Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Amiodarone Sales by Country: 2021 VS 2025 VS 2032 (m units) Figure 58. Latin America Amiodarone Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Amiodarone Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Latin America Amiodarone Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Amiodarone Sales by Country: 2021 VS 2025 VS 2032 (m units) Figure 62. Middle East and Africa Amiodarone Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Amiodarone Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Middle East and Africa Amiodarone Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Amiodarone Value Chain Figure 66. Key Raw Materials Price Figure 67. Manufacturing Cost Structure Figure 68. Amiodarone Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Injection Amiodarone
  • Tablet Amiodarone
  • Capsule Amiodarone
Applications
  • Ventricular Tachycardia
  • Atrial Fibrillation
  • Cardiac Arrest
  • Others
Companies covered
  • Shanghai Pharmaceuticals
  • Sanofi
  • Mylan Pharmaceuticals
  • North China Pharmaceutical Company
  • Harbin Pharmaceutical Group
  • Wyeth Pharmaceuticals (Pfizer)
  • Sawai Pharmaceutical
  • Roemmers
  • Cipla Pharmaceutical
  • Arrow Pharma Pty Ltd

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Amiodarone Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Amiodarone Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Amiodarone Market by Type
  6. 1.3.1 Injection Amiodarone
  7. 1.3.2 Tablet Amiodarone
  8. 1.3.3 Capsule Amiodarone
  9. 1.4 Global Amiodarone Market Size by Type
  10. 1.4.1 Global Amiodarone Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Amiodarone Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Amiodarone Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Amiodarone Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Amiodarone Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Amiodarone Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Amiodarone Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Amiodarone Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Amiodarone Industry Trends
  2. 2.2 Amiodarone Industry Drivers
  3. 2.3 Amiodarone Industry Opportunities and Challenges
  4. 2.4 Amiodarone Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Amiodarone Revenue (2021-2026)
  2. 3.2 Global Top Players by Amiodarone Sales (2021-2026)
  3. 3.3 Global Top Players by Amiodarone Price (2021-2026)
  4. 3.4 Global Amiodarone Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Amiodarone Major Company Production Sites & Headquarters
  6. 3.6 Global Amiodarone Company, Product Type & Application
  7. 3.7 Global Amiodarone Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Amiodarone Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Amiodarone Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Amiodarone Tier 1, Tier 2, and Tier 3
4 Amiodarone Regional Status and Outlook
  1. 4.1 Global Amiodarone Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Amiodarone Historic Market Size by Region
  3. 4.2.1 Global Amiodarone Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Amiodarone Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Amiodarone Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Amiodarone Forecasted Market Size by Region
  7. 4.3.1 Global Amiodarone Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Amiodarone Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Amiodarone Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Amiodarone by Application
  1. 5.1 Amiodarone Market by Application
  2. 5.1.1 Ventricular Tachycardia
  3. 5.1.2 Atrial Fibrillation
  4. 5.1.3 Cardiac Arrest
  5. 5.1.4 Others
  6. 5.2 Global Amiodarone Market Size by Application
  7. 5.2.1 Global Amiodarone Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Amiodarone Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Amiodarone Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Amiodarone Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Amiodarone Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Amiodarone Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Amiodarone Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Amiodarone Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Shanghai Pharmaceuticals
  2. 6.1.1 Shanghai Pharmaceuticals Company Information
  3. 6.1.2 Shanghai Pharmaceuticals Business Overview
  4. 6.1.3 Shanghai Pharmaceuticals Amiodarone Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Shanghai Pharmaceuticals Amiodarone Product Portfolio
  6. 6.1.5 Shanghai Pharmaceuticals Recent Developments
  7. 6.2 Sanofi
  8. 6.2.1 Sanofi Company Information
  9. 6.2.2 Sanofi Business Overview
  10. 6.2.3 Sanofi Amiodarone Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Sanofi Amiodarone Product Portfolio
  12. 6.2.5 Sanofi Recent Developments
  13. 6.3 Mylan Pharmaceuticals
  14. 6.3.1 Mylan Pharmaceuticals Company Information
  15. 6.3.2 Mylan Pharmaceuticals Business Overview
  16. 6.3.3 Mylan Pharmaceuticals Amiodarone Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Mylan Pharmaceuticals Amiodarone Product Portfolio
  18. 6.3.5 Mylan Pharmaceuticals Recent Developments
  19. 6.4 North China Pharmaceutical Company
  20. 6.4.1 North China Pharmaceutical Company Company Information
  21. 6.4.2 North China Pharmaceutical Company Business Overview
  22. 6.4.3 North China Pharmaceutical Company Amiodarone Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 North China Pharmaceutical Company Amiodarone Product Portfolio
  24. 6.4.5 North China Pharmaceutical Company Recent Developments
  25. 6.5 Harbin Pharmaceutical Group
  26. 6.5.1 Harbin Pharmaceutical Group Company Information
  27. 6.5.2 Harbin Pharmaceutical Group Business Overview
  28. 6.5.3 Harbin Pharmaceutical Group Amiodarone Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Harbin Pharmaceutical Group Amiodarone Product Portfolio
  30. 6.5.5 Harbin Pharmaceutical Group Recent Developments
  31. 6.6 Wyeth Pharmaceuticals (Pfizer)
  32. 6.6.1 Wyeth Pharmaceuticals (Pfizer) Company Information
  33. 6.6.2 Wyeth Pharmaceuticals (Pfizer) Business Overview
  34. 6.6.3 Wyeth Pharmaceuticals (Pfizer) Amiodarone Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Wyeth Pharmaceuticals (Pfizer) Amiodarone Product Portfolio
  36. 6.6.5 Wyeth Pharmaceuticals (Pfizer) Recent Developments
  37. 6.7 Sawai Pharmaceutical
  38. 6.7.1 Sawai Pharmaceutical Company Information
  39. 6.7.2 Sawai Pharmaceutical Business Overview
  40. 6.7.3 Sawai Pharmaceutical Amiodarone Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Sawai Pharmaceutical Amiodarone Product Portfolio
  42. 6.7.5 Sawai Pharmaceutical Recent Developments
  43. 6.8 Roemmers
  44. 6.8.1 Roemmers Company Information
  45. 6.8.2 Roemmers Business Overview
  46. 6.8.3 Roemmers Amiodarone Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Roemmers Amiodarone Product Portfolio
  48. 6.8.5 Roemmers Recent Developments
  49. 6.9 Cipla Pharmaceutical
  50. 6.9.1 Cipla Pharmaceutical Company Information
  51. 6.9.2 Cipla Pharmaceutical Business Overview
  52. 6.9.3 Cipla Pharmaceutical Amiodarone Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Cipla Pharmaceutical Amiodarone Product Portfolio
  54. 6.9.5 Cipla Pharmaceutical Recent Developments
  55. 6.10 Arrow Pharma Pty Ltd
  56. 6.10.1 Arrow Pharma Pty Ltd Company Information
  57. 6.10.2 Arrow Pharma Pty Ltd Business Overview
  58. 6.10.3 Arrow Pharma Pty Ltd Amiodarone Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Arrow Pharma Pty Ltd Amiodarone Product Portfolio
  60. 6.10.5 Arrow Pharma Pty Ltd Recent Developments
7 North America by Country
  1. 7.1 North America Amiodarone Sales by Country
  2. 7.1.1 North America Amiodarone Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Amiodarone Sales by Country (2021-2026)
  4. 7.1.3 North America Amiodarone Sales Forecast by Country (2027-2032)
  5. 7.2 North America Amiodarone Market Size by Country
  6. 7.2.1 North America Amiodarone Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Amiodarone Market Size by Country (2021-2026)
  8. 7.2.3 North America Amiodarone Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Amiodarone Sales by Country
  2. 8.1.1 Europe Amiodarone Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Amiodarone Sales by Country (2021-2026)
  4. 8.1.3 Europe Amiodarone Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Amiodarone Market Size by Country
  6. 8.2.1 Europe Amiodarone Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Amiodarone Market Size by Country (2021-2026)
  8. 8.2.3 Europe Amiodarone Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Amiodarone Sales by Country
  2. 9.1.1 Asia-Pacific Amiodarone Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Amiodarone Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Amiodarone Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Amiodarone Market Size by Country
  6. 9.2.1 Asia-Pacific Amiodarone Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Amiodarone Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Amiodarone Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Amiodarone Sales by Country
  2. 10.1.1 South America Amiodarone Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Amiodarone Sales by Country (2021-2026)
  4. 10.1.3 South America Amiodarone Sales Forecast by Country (2027-2032)
  5. 10.2 South America Amiodarone Market Size by Country
  6. 10.2.1 South America Amiodarone Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Amiodarone Market Size by Country (2021-2026)
  8. 10.2.3 South America Amiodarone Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Amiodarone Sales by Country
  2. 11.1.1 Middle East and Africa Amiodarone Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Amiodarone Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Amiodarone Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Amiodarone Market Size by Country
  6. 11.2.1 Middle East and Africa Amiodarone Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Amiodarone Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Amiodarone Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Amiodarone Value Chain Analysis
  2. 12.1.1 Amiodarone Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Amiodarone Production Mode & Process
  7. 12.2 Amiodarone Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Amiodarone Distributors
  10. 12.2.3 Amiodarone Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst